These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
423 related items for PubMed ID: 32703312
1. Mass-forming pancreatitis versus pancreatic ductal adenocarcinoma: CT and MR imaging for differentiation. Schima W, Böhm G, Rösch CS, Klaus A, Függer R, Kopf H. Cancer Imaging; 2020 Jul 23; 20(1):52. PubMed ID: 32703312 [Abstract] [Full Text] [Related]
2. Pancreatitis and PDAC: association and differentiation. Elsherif SB, Virarkar M, Javadi S, Ibarra-Rovira JJ, Tamm EP, Bhosale PR. Abdom Radiol (NY); 2020 May 23; 45(5):1324-1337. PubMed ID: 31705251 [Abstract] [Full Text] [Related]
3. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma. Jia H, Li J, Huang W, Lin G. BMC Med Imaging; 2021 Oct 15; 21(1):149. PubMed ID: 34654379 [Abstract] [Full Text] [Related]
4. Intravoxel incoherent motion diffusion-weighted imaging of the pancreas: Characterization of benign and malignant pancreatic pathologies. Kim B, Lee SS, Sung YS, Cheong H, Byun JH, Kim HJ, Kim JH. J Magn Reson Imaging; 2017 Jan 15; 45(1):260-269. PubMed ID: 27273754 [Abstract] [Full Text] [Related]
5. Chronic Pancreatitis or Pancreatic Tumor? A Problem-solving Approach. Wolske KM, Ponnatapura J, Kolokythas O, Burke LMB, Tappouni R, Lalwani N. Radiographics; 2019 Jan 15; 39(7):1965-1982. PubMed ID: 31584860 [Abstract] [Full Text] [Related]
7. MRI features for differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. Ha J, Choi SH, Kim KW, Kim JH, Kim HJ. Dig Liver Dis; 2022 Jul 15; 54(7):849-856. PubMed ID: 34903501 [Abstract] [Full Text] [Related]
8. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions. Aslan S, Nural MS, Camlidag I, Danaci M. Abdom Radiol (NY); 2019 Feb 15; 44(2):593-603. PubMed ID: 30225610 [Abstract] [Full Text] [Related]
9. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings. Choi SY, Kim SH, Kang TW, Song KD, Park HJ, Choi YH. AJR Am J Roentgenol; 2016 Feb 15; 206(2):291-300. PubMed ID: 26797355 [Abstract] [Full Text] [Related]
10. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping. Kim M, Jang KM, Kim JH, Jeong WK, Kim SH, Kang TW, Kim YK, Cha DI, Kim K. Eur Radiol; 2017 Apr 15; 27(4):1722-1732. PubMed ID: 27510628 [Abstract] [Full Text] [Related]
11. Two nomograms for differentiating mass-forming chronic pancreatitis from pancreatic ductal adenocarcinoma in patients with chronic pancreatitis. Zhang H, Meng Y, Li Q, Yu J, Liu F, Fang X, Li J, Feng X, Zhou J, Zhu M, Li N, Lu J, Shao C, Bian Y. Eur Radiol; 2022 Sep 15; 32(9):6336-6347. PubMed ID: 35394185 [Abstract] [Full Text] [Related]
12. Intravoxel incoherent motion DWI of the pancreatic adenocarcinomas: monoexponential and biexponential apparent diffusion parameters and histopathological correlations. Ma C, Li Y, Wang L, Wang Y, Zhang Y, Wang H, Chen S, Lu J. Cancer Imaging; 2017 Apr 28; 17(1):12. PubMed ID: 28454564 [Abstract] [Full Text] [Related]
13. Pancreatic Cancer and Its Mimics. Miller FH, Lopes Vendrami C, Hammond NA, Mittal PK, Nikolaidis P, Jawahar A. Radiographics; 2023 Nov 28; 43(11):e230054. PubMed ID: 37824413 [Abstract] [Full Text] [Related]
14. Atypical and uncommon CT and MR imaging presentations of pancreatic ductal adenocarcinoma. Gong XH, Xu JR, Qian LJ. Abdom Radiol (NY); 2021 Sep 28; 46(9):4226-4237. PubMed ID: 33914139 [Abstract] [Full Text] [Related]
15. Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma. Ren S, Zhao R, Zhang J, Guo K, Gu X, Duan S, Wang Z, Chen R. Abdom Radiol (NY); 2020 May 28; 45(5):1524-1533. PubMed ID: 32279101 [Abstract] [Full Text] [Related]
16. The role of apparent diffusion coefficient value in the diagnosis of localized type 1 autoimmune pancreatitis: differentiation from pancreatic ductal adenocarcinoma and evaluation of response to steroids. Sekito T, Ishii Y, Serikawa M, Tsuboi T, Kawamura R, Tsushima K, Nakamura S, Hirano T, Fukiage A, Mori T, Ikemoto J, Kiyoshita Y, Saeki S, Tamura Y, Miyamoto S, Chayama K. Abdom Radiol (NY); 2021 May 28; 46(5):2014-2024. PubMed ID: 33386451 [Abstract] [Full Text] [Related]
17. The role of EUS in relation to other imaging modalities in the differential diagnosis between mass forming chronic pancreatitis, autoimmune pancreatitis and ductal pancreatic adenocarcinoma. Iglesias-García J, Lindkvist B, Lariño-Noia J, Domínguez-Muñoz JE. Rev Esp Enferm Dig; 2012 Jun 28; 104(6):315-21. PubMed ID: 22738702 [Abstract] [Full Text] [Related]
18. Intravoxel incoherent motion magnetic resonance imaging for differentiating metastatic and non-metastatic lymph nodes in pancreatic ductal adenocarcinoma. Rong D, Mao Y, Hu W, Xu S, Wang J, He H, Li S, Zhang R. Eur Radiol; 2018 Jul 28; 28(7):2781-2789. PubMed ID: 29404768 [Abstract] [Full Text] [Related]
19. Large Duct Pancreatic Ductal Adenocarcinoma: A Morphological Variant of Pancreatic Ductal Adenocarcinoma With Distinct CT and MRI Characteristics. Choi SJ, Kim SJ, Kim DW, Lee SS, Hong SM, Kim KW, Kim JH, Kim HJ, Byun JH. Korean J Radiol; 2023 Dec 28; 24(12):1232-1240. PubMed ID: 38016682 [Abstract] [Full Text] [Related]
20. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis. Lee JH, Min JH, Kim YK, Cha DI, Lee J, Park HJ, Ahn S. Clin Imaging; 2019 Dec 28; 55():132-139. PubMed ID: 30818163 [Abstract] [Full Text] [Related] Page: [Next] [New Search]